Yongkui Yu
Overview
Explore the profile of Yongkui Yu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang P, Wang S, Huang Q, Chen X, Yu Y, Zhang R, et al.
BMC Med
. 2025 Feb;
23(1):113.
PMID: 39988705
Background: Systemic nutrition and inflammation status is recognized for its influence on cancer survival, yet its role in perioperative outcomes remains poorly defined. This study aimed to refine the assessment...
2.
Zheng Y, Liang G, Yuan D, Liu X, Ba Y, Qin Z, et al.
Cancer Commun (Lond)
. 2024 Sep;
44(10):1214-1227.
PMID: 39221992
Background: In the era of immunotherapy, neoadjuvant immunochemotherapy (NAIC) for the treatment of locally advanced esophageal squamous cell carcinoma (ESCC) is used clinically but lacks of high-level clinical evidence. This...
3.
Gu X, Liu D, Yu Y, Wang H, Long D
J Am Chem Soc
. 2023 Apr;
145(18):10295-10303.
PMID: 37116086
Peripheral membrane proteins can adopt distinct orientations on the surfaces of lipid bilayers that are often short-lived and challenging to characterize by conventional experimental methods. Here we describe a robust...
4.
Wang H, Liu D, Yu Y, Fang M, Gu X, Long D
Phys Chem Chem Phys
. 2022 Dec;
25(2):1045-1053.
PMID: 36537570
Recent advances in direct inhibition of Ras benefit from the protein's intrinsic dynamic nature that derives therapeutically vulnerable conformers bearing transiently formed cryptic pockets. Hotspot mutants of Ras are major...
5.
Yu Y, Wei X, Chen X, Li H, Liu Q, Sun H, et al.
Thorac Cancer
. 2022 Nov;
14(2):127-134.
PMID: 36382366
Objectives: The latest version of the National Comprehensive Cancer Network recommends neoadjuvant therapy followed by surgical treatment or radical chemoradiotherapy for patients with cT3N0M0. Neoadjuvant therapy can improve the prognosis...
6.
Wei X, Luo P, Chen X, Wang Z, Xu L, Xie H, et al.
Thorac Cancer
. 2022 Oct;
13(23):3304-3309.
PMID: 36226869
Background: This study aimed to investigate the value and efficiency of routine brain MRI or CT in the preoperative workup for patients with potentially resectable (cT N ) thoracic esophageal...
7.
Ma H, Yao D, Cheng J, Wang W, Liu B, Yu Y, et al.
J Thorac Dis
. 2022 Jul;
14(6):2178-2186.
PMID: 35813764
Background: Various reports showed some conflicting data on survival at different ages. This study aimed to investigate the main cause of death in older patients with lung cancer and to...
8.
Chen X, Wang P, Leng C, Sun H, Liu X, Zhang R, et al.
Surgery
. 2022 Jul;
172(3):919-925.
PMID: 35794044
Background: The impact of early oral feeding after esophagectomy on brain-gut peptide secretion and gut function recovery has not been well investigated. This study aimed to fill this research gap....
9.
Wang W, Yu Y, Sun H, Wang Z, Zheng Y, Liang G, et al.
J Gastrointest Oncol
. 2022 May;
13(2):488-498.
PMID: 35557590
Background: Postoperative pneumonia (PP) is the most common pulmonary complication of esophagectomy. It is of great importance to identify any high-risk factors and prevent pulmonary complications to improve the prognosis...
10.
Yu Y, Xu L, Chen X, Li H, Liu Q, Zhang R, et al.
Ann Transl Med
. 2022 Apr;
10(6):349.
PMID: 35434045
Background: Multiple clinical trials were conducted to evaluate the efficacy of neoadjuvant therapy in esophageal cancer but exhibited mixed results, indicating that the efficacy of neoadjuvant therapy remains controversial in...